Abstract
MTA1 is a metastasis-associated protein, which is essential to epithelial-to-mesenchymal transition (EMT). However, information concerning its up- and downstream regulation is rare. We investigated its upstream regulation and downstream effector in human hepatocellular carcinoma (HCC). In total, 94 paired HCC and adjacent tissue samples were involved in the study, and the results indicated that decreased miR-30e levels were associated with increased MTA1 levels in human HCC. miR-30e exerted its regulation of MTA1 transcription by binding to its 3′-untranslated region, and was negatively associated with EMT. Furthermore, significantly higher expression of MTA1 was associated with overexpression of v-erb-b2 avian erythroblastic leukemia viral oncogene homolog 2 (ErbB2) in human HCC, and MTA1 can promote transcription of ErbB2 by binding with histone deacetylase 2 (HDAC2) and acting as a promoter. The EMT promotion effect caused by MTA1 largely depended on ErbB2, and reducing the activity of ErbB2 can significantly attenuate EMT promotion by causing overexpression of MTA1 both in vitro and in vivo. In general, downregulation of miR-30e can increase levels of MTA1 in human HCC, and furthermore promote cell invasion and metastasis by promoting ErbB2.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 50 print issues and online access
$259.00 per year
only $5.18 per issue
Rent or buy this article
Prices vary by article type
from$1.95
to$39.95
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
He Y, Meng XM, Huang C, Wu BM, Zhang L, Lv XW et al. Long noncoding RNAs: novel insights into hepatocelluar carcinoma. Cancer Lett 2014; 344: 20–27.
Wang L, Zou ZQ, Liu CX, Liu XZ . Immunotherapeutic interventions in chronic hepatitis B virus infection: a review. J Immunol Methods 2014; 407: 1–8.
Wang Y, Tian Y . miRNA for diagnosis and clinical implications of human hepatocellular carcinoma. Hepatol Res 2016; 46: 89–99.
Hayes CN, Chayama K . MicroRNAs as biomarkers for liver disease and hepatocellular carcinoma. Int J Mol Sci 2016; 17: 280.
Li DQ, Pakala SB, Nair SS, Eswaran J, Kumar R . Metastasis-associated protein 1/nucleosome remodeling and histone deacetylase complex in cancer. Cancer Res 2012; 72: 387–394.
Sen N, Gui B, Kumar R . Role of MTA1 in cancer progression and metastasis. Cancer Metastasis Rev 2014; 33: 879–889.
Zhu W, Cai MY, Tong ZT, Dong SS, Mai SJ, Liao YJ et al. Overexpression of EIF5A2 promotes colorectal carcinoma cell aggressiveness by upregulating MTA1 through C-myc to induce epithelial-mesenchymaltransition. Gut 2012; 61: 562–575.
Nair SS, Bommana A, Pakala SB, Ohshiro K, Lyon AJ, Suttiprapa S et al. Inflammatory response to liver fluke Opisthorchis viverrini in mice depends on host master coregulator MTA1, a marker for parasite-induced cholangiocarcinoma in humans. Hepatology 2011; 54: 1388–1397.
Ryu SH, Chung YH, Lee H, Kim JA, Shin HD, Min HJ et al. Metastatic tumor antigen 1 is closely associated with frequent postoperative recurrence and poor survival in patients with hepatocellular carcinoma. Hepatology 2008; 47: 929–936.
Ahmad A, Sarkar SH, Bitar B, Ali S, Aboukameel A, Sethi S et al. Garcinol regulates EMT and Wnt signaling pathways in vitro and in vivo, leading to anticancer activity against breast cancer cells. Mol Cancer Ther 2012; 11: 2193–2201.
Xia Y, Chen Q, Zhong Z, Xu C, Wu C, Liu B et al. Down-regulation of miR-30c promotes the invasion of non-small cell lung cancer by targeting MTA1. Cell Physiol Biochem 2013; 32: 476–485.
Bruzzese F, Leone A, Rocco M, Carbone C, Piro G, Caraglia M et al. HDAC inhibitor vorinostat enhances the antitumor effect of gefitinib in squamous cell carcinoma of head and neck by modulating ErbB receptor expression and reverting EMT. J Cell Physiol 2011; 226: 2378–2390.
Gupta P, Srivastava SK . HER2 mediated de novo production of TGFbeta leads to SNAIL driven epithelial-to-mesenchymal transition and metastasis of breast cancer. Mol Oncol 2014; 8: 1532–1547.
Jenndahl LE, Isakson P, Baeckstrom D . c-erbB2-induced epithelial-mesenchymal transition in mammary epithelial cells is suppressed by cell-cell contact and initiated prior to E-cadherin downregulation. Int J Oncol 2005; 27: 439–448.
Tkach M, Thery C . Communication by extracellular vesicles: where we are and where we need to go. Cell 2016; 164: 1226–1232.
van der Burg SH, Arens R, Ossendorp F, van Hall T, Melief CJ . Vaccines for established cancer: overcoming the challenges posed by immune evasion. Nat Rev Cancer 2016; 16: 219–233.
Bruning A, Blankenstein T, Juckstock J, Mylonas I . Function and regulation of MTA1 and MTA3 in malignancies of the female reproductive system. Cancer Metastasis Rev 2014; 33: 943–951.
Levenson AS, Kumar A, Zhang X . MTA family of proteins in prostate cancer: biology, significance, and therapeutic opportunities. Cancer Metastasis Rev 2014; 33: 929–942.
Manavathi B, Singh K, Kumar R . MTA family of coregulators in nuclear receptor biology and pathology. Nuclear Receptor Signal 2007; 5: e010.
Bhattacharya S, Steele R, Shrivastava S, Chakraborty S, Di Bisceglie AM, Ray RB . Serum miR-30e and miR-223 as novel noninvasive biomarkers for hepatocellular carcinoma. Am J Pathol 2016; 186: 242–247.
Toh Y, Pencil SD, Nicolson GL . A novel candidate metastasis-associated gene, mta1, differentially expressed in highly metastatic mammary adenocarcinoma cell lines. cDNA cloning, expression, and protein analyses. J Biol Chem 1994; 269: 22958–22963.
Deng L, Yang H, Tang J, Lin Z, Yin A, Gao Y et al. Inhibition of MTA1 by ERalpha contributes to protection hepatocellular carcinoma from tumor proliferation and metastasis. J Exp Clin Cancer Res 2015; 34: 128.
Hamatsu T, Rikimaru T, Yamashita Y, Aishima S, Tanaka S, Shirabe K et al. The role of MTA1 gene expression in human hepatocellular carcinoma. Oncol Rep 2003; 10: 599–604.
Yoo YG, Na TY, Seo HW, Seong JK, Park CK, Shin YK et al. Hepatitis B virus X protein induces the expression of MTA1 and HDAC1, which enhances hypoxia signaling in hepatocellular carcinoma cells. Oncogene 2008; 27: 3405–3413.
Pakala SB, Singh K, Reddy SD, Ohshiro K, Li DQ, Mishra L et al. TGF-beta1 signaling targets metastasis-associated protein 1, a new effector in epithelial cells. Oncogene 2011; 30: 2230–2241.
Zhang XY, DeSalle LM, Patel JH, Capobianco AJ, Yu D, Thomas-Tikhonenko A et al. Metastasis-associated protein 1 (MTA1) is an essential downstream effector of the c-MYC oncoprotein. Proc Natl Acad Sci USA 2005; 102: 13968–13973.
Acknowledgements
This work was supported by grants from the National Natural Science Foundation (81201880 to LD, 81201528, 81572370 to RJ and 81430062 to BS), Six talent peaks project in Jiangsu Province (2013-wsw-20 to RJ). National Key Research and Development Program of China (2016YFC0905900 to BS).
Author information
Authors and Affiliations
Corresponding authors
Ethics declarations
Competing interests
The authors declare no conflict of interest.
Additional information
Supplementary Information accompanies this paper on the Oncogene website
Rights and permissions
About this article
Cite this article
Deng, L., Tang, J., Yang, H. et al. MTA1 modulated by miR-30e contributes to epithelial-to-mesenchymal transition in hepatocellular carcinoma through an ErbB2-dependent pathway. Oncogene 36, 3976–3985 (2017). https://doi.org/10.1038/onc.2016.491
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/onc.2016.491
This article is cited by
-
Metastasis-associated protein 1: A potential driver and regulator of the hallmarks of cancer
Journal of Biosciences (2022)
-
CircPVT1 promotes proliferation of lung squamous cell carcinoma by binding to miR-30d/e
Journal of Experimental & Clinical Cancer Research (2021)
-
A TGF-β-MTA1-SOX4-EZH2 signaling axis drives epithelial–mesenchymal transition in tumor metastasis
Oncogene (2020)
-
In silico approach in reveal traditional medicine plants pharmacological material basis
Chinese Medicine (2018)
-
MicroRNA-transcription factor network analysis reveals miRNAs cooperatively suppress RORA in oral squamous cell carcinoma
Oncogenesis (2018)